3

PRIMARY DOCUMENT

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: March 10, 2021
Period of Report: March 9, 2021
Accession Number: 0001735276-21-000030

View Document ↗ View on SEC.gov ↗